How Glenmark convinced its investors to back its high-risk R&D strategy

While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.

11 February, 202510 min
0
Getting your Trinity Audio player ready...
How Glenmark convinced its investors to back its high-risk R&D strategy

You may also like

Chaos
Story image

India-US trade pact demonstrates how sovereignty is eroded in practice

The framework reads less like an agreement between partners and more like a probation order written by the stronger side.

Chaos
Story image

India needs to stop courting the US and look for a solid plan B

It’s never a good sign when your foreign minister needs a lobbyist to meet US officials. The recent events signal a breakdown in the Modi government’s ability to operate in today’s Washington through its own machinery.

Business
Story image

The 72 hours that saw IndiGo unravel

A crew crunch, new regulatory norms and simmering discontent push India’s biggest airline into its biggest crisis yet, one that could seriously dent its reputation for reliability.